EXPO Exponent (EXPO) Insider Trading, Ownership & Congress Trades
Services · Services-management consulting services · CIK 0000851520
C-suite buying · 1Form 144 · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
160
13F, latest reported quarter
Conversions, 180 days
13
Codes C/M, not in net · $1.1M priced
What the filings say about EXPO
Insiders, 180 days
-$1.2M net sold
1 buyer · 5 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-09-11
Planned sales (Form 144), 90 days
$114.5K
1 notice
Exponent insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, EXPONENT INC insiders sold a net $1.2M of stock across 150 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 0.5% of the 40,873 shares held after it.
- No other insider bought within 30 days.
- 160 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Group Vice President Souri Shukri Jeries bought about $12.6K of EXPO on Sep 18, 2026, the largest insider purchase at the company since 2022; 160 funds added in the latest 13F quarter.Context
- 21 earlier Form 4 trades (code P or S) here by this insider (21 sales), the last on Jul 15, 2026.
- The trade is 1.3% of the 129,108 shares held after it.
- No other insider sold within 30 days.
- 160 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Corrigan Catherine sold about $113.1K of EXPO on Aug 17, 2026; 160 funds added in the latest 13F quarter.Context
- 20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Jun 15, 2026.
- The trade is 1.5% of the 115,771 shares held after it.
- No other insider sold within 30 days.
- 160 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Corrigan Catherine sold about $109.0K of EXPO on Jul 15, 2026; 160 funds added in the latest 13F quarter.Context
- 18 earlier Form 4 trades (code P or S) here by this insider (18 sales), the last on May 15, 2026.
- The trade is 1.7% of the 107,257 shares held after it.
- 2 other insiders sold within 30 days.
- 160 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Corrigan Catherine sold about $102.4K of EXPO on Jun 15, 2026; 2 other insiders sold within 30 days and 160 funds added in the latest 13F quarter.Context
- 18 earlier Form 4 trades (code P or S) here by this insider (18 sales), the last on May 15, 2026.
- The trade is 2.2% of the 106,670 shares held after it.
- 2 other insiders sold within 30 days.
- 160 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Corrigan Catherine sold about $132.9K of EXPO on Jun 15, 2026; 2 other insiders sold within 30 days and 160 funds added in the latest 13F quarter.150 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$1.2M over 180 days
-$100.5K over 90 days
below 57% of Services
Congress
no House purchase disclosed in the last 12 months
Funds
160 funds bought in last quarter
more than 67% of Services
Revenue
+4.2% year over year
below 53% of Services
Margin
18.2% net margin
more than 86% of Services
Buybacks
$146.1M repurchased, FY to 2026-07-03
more than 64% of Services
Short interest
5.8% of the float short (float per yahoo 2026-10-26) · 4.4 days to cover · settled 2026-09-30
more than 72% of Services
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch EXPO
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+14.1%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns EXPO: institutional holders (13F)
13F holdings, latest reported quarter
6,184,950 sh
$363.4M
3,995,684 sh
$234.8M
3,143,624 sh
$184.7M
2,180,212 sh
$128.1M
1,943,646 sh
$114.2M
Congress trades in EXPO
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-09-11 · disclosed 41 days later
$1,001 - $15,000
Bought 2025-08-13 · disclosed 30 days later
$1,001 - $15,000
Sold 2025-05-12 · disclosed 41 days later
$15,001 - $50,000
Bought 2025-03-13 · disclosed 29 days later
$15,001 - $50,000
Bought 2025-02-24 · disclosed 13 days later
$15,001 - $50,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
EXPO planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
CATHERINE CORRIGAN
Filed 2026-08-17
$114.5K
CATHERINE CORRIGAN
Filed 2026-07-15
$107.8K
EXPO mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
FAM SMALL CAP FUND
$11.5M position · as of 2026-06-30
3.7%
Geneva SMID Cap Growth Fund
$1.4M position · as of 2026-05-31
3.1%
Nationwide Geneva Small Cap Growth Fund
$23.0M position · as of 2026-07-31
2.6%
Virtus KAR Small-Mid Cap Core Fund
$26.8M position · as of 2026-06-30
2.5%
Royce Premier Fund
$23.4M position · as of 2026-06-30
2.0%
Virtus KAR Mid-Cap Core Fund
$32.6M position · as of 2026-06-30
1.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$3.7M
$2.5M
$2.0M
-18%
+57%
2024
$3.5M
$3.5M
$1.9M
+3%
+45%
2023
$3.6M
$2.8M
$1.9M
+1%
+26%
2022
$3.6M
$2.3M
$1.6M
+12%
+8%
2021
$3.0M
$5.2M
$1.5M
+31%
+25%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.2M sold by insiders over 180 days, 160 funds added last quarter, $114.5K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
EXPO financials
Revenue growth
+4.2%
XBRL, annual
Net margin
18.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$632.5M
four quarters, 2025-07-05 to 2026-07-03
Revenue, TTM EXPO
| FY Jan 2026 | $582.0M |
| FY Jan 2025 | $558.5M |
| FY Dec 2023 | $536.8M |
| FY Dec 2022 | $513.3M |
| FY Dec 2021 | $466.3M |
| Jul 2026 | $171.6M |
| Apr 2026 | $166.3M |
| Jan 2026 | $147.4M |
| Oct 2025 | $147.1M |
| Jul 2025 | $142.0M |
| Apr 2025 | $145.5M |
| Jan 2025 | $136.8M |
| Sep 2024 | $136.3M |
At each fiscal year end
Single quarter
Net margin, TTM
+17.7%
net income over revenue, 2025-07-05 to 2026-07-03
Net margin, TTM EXPO
| FY Jan 2026 | +18.2% |
| FY Jan 2025 | +19.5% |
| FY Dec 2023 | +18.7% |
| FY Dec 2022 | +19.9% |
| FY Dec 2021 | +21.7% |
| Jul 2026 | +17.1% |
| Apr 2026 | +17.8% |
| Jan 2026 | +16.8% |
| Oct 2025 | +19.1% |
| Jul 2025 | +18.7% |
| Apr 2025 | +18.3% |
| Jan 2025 | +17.2% |
| Sep 2024 | +19.1% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$108.6M
operating cash flow minus capex, 2025-07-05 to 2026-07-03
Free cash flow, TTM EXPO
| FY Jan 2026 | $122.3M |
| FY Jan 2025 | $137.6M |
| FY Dec 2023 | $111.0M |
| FY Dec 2022 | $81.8M |
| FY Dec 2021 | $117.7M |
| Jul 2026 | $29.1M |
| Apr 2026 | -$3.4M |
| Jan 2026 | $52.9M |
| Oct 2025 | $30.0M |
| Jul 2025 | $33.9M |
| Apr 2025 | $5.5M |
| Jan 2025 | $53.5M |
| Sep 2024 | $28.0M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity EXPO
| FY Jan 2026 | n/a |
| FY Jan 2025 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt EXPO
| FY Jan 2026 | n/a |
| FY Jan 2025 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+31.2%
TTM net income over average of 2025-07-04 and 2026-07-03
Return on equity EXPO
| FY Jan 2026 | +26.1% |
| FY Jan 2025 | +28.1% |
| FY Dec 2023 | +29.6% |
| FY Dec 2022 | +27.7% |
| FY Dec 2021 | +26.0% |
| Jul 2026 | +31.2% |
| Apr 2026 | +27.9% |
| Jan 2026 | +26.1% |
| Oct 2025 | +25.8% |
| Jul 2025 | +25.1% |
| Apr 2025 | +25.9% |
| Jan 2025 | +28.1% |
| Sep 2024 | +27.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+15.8%
TTM net income over average of 2025-07-04 and 2026-07-03
Return on assets EXPO
| FY Jan 2026 | +13.6% |
| FY Jan 2025 | +15.3% |
| FY Dec 2023 | +16.3% |
| FY Dec 2022 | +16.1% |
| FY Dec 2021 | +16.0% |
| Jul 2026 | +15.8% |
| Apr 2026 | +15.0% |
| Jan 2026 | +13.6% |
| Oct 2025 | +13.9% |
| Jul 2025 | +14.0% |
| Apr 2025 | +15.2% |
| Jan 2025 | +15.3% |
| Sep 2024 | +15.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
Return on invested capital EXPO
| FY Jan 2026 | n/a |
| FY Jan 2025 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+22.8%
operating income (EBIT proxy) over average of 2025-07-04 and 2026-07-03 minus current liabilities
Return on capital employed EXPO
| FY Jan 2026 | +19.7% |
| FY Jan 2025 | +21.8% |
| FY Dec 2023 | +24.4% |
| FY Dec 2022 | +29.4% |
| FY Dec 2021 | +21.9% |
| Jul 2026 | +22.8% |
| Apr 2026 | +19.8% |
| Jan 2026 | +19.7% |
| Oct 2025 | +19.4% |
| Jul 2025 | +19.1% |
| Apr 2025 | +23.2% |
| Jan 2025 | +21.8% |
| Sep 2024 | +20.5% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
34.83x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-05 to 2026-07-03
P/E, trailing EXPO
| FY Jan 2026 | 33.73x |
| FY Jan 2025 | 42.14x |
| FY Dec 2023 | 45.38x |
| FY Dec 2022 | 50.56x |
| FY Dec 2021 | 61.44x |
| Jul 2026 | 27.35x |
| Apr 2026 | 30.96x |
| Jan 2026 | 33.73x |
| Oct 2025 | 32.89x |
| Jul 2025 | 38.74x |
| Apr 2025 | 37.77x |
| Jan 2025 | 42.14x |
| Sep 2024 | 54.98x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value EXPO
| FY Jan 2026 | n/a |
| FY Jan 2025 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.9%
TTM free cash flow over market value at close 2026-10-26
FCF yield EXPO
| FY Jan 2026 | +3.5% |
| FY Jan 2025 | +3.0% |
| FY Dec 2023 | +2.5% |
| FY Dec 2022 | +1.6% |
| FY Dec 2021 | +1.9% |
| Jul 2026 | +3.7% |
| Apr 2026 | +3.5% |
| Jan 2026 | +3.5% |
| Oct 2025 | +3.6% |
| Jul 2025 | +3.1% |
| Apr 2025 | +3.4% |
| Jan 2025 | +3.0% |
| Sep 2024 | +2.7% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
2.89x
P/E over trailing EPS growth of 12%: four quarters to 2026-07-03 against the four to 2025-07-04
PEG, trailing EXPO
| FY Jan 2026 | n/a |
| FY Jan 2025 | 4.81x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 16.01x |
| FY Dec 2021 | 2.72x |
| Jul 2026 | 2.27x |
| Apr 2026 | 5.74x |
| Jan 2026 | n/a |
| Oct 2025 | n/a |
| Jul 2025 | n/a |
| Apr 2025 | 10.63x |
| Jan 2025 | 4.81x |
| Sep 2024 | 13.61x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-01 | 2025-01 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $582.0M | $558.5M | $536.8M | $513.3M |
| Operating income | $119.8M | $119.6M | $111.3M | $140.8M |
| Net income | $106.0M | $109.0M | $100.3M | $102.3M |
| EPS (diluted) | 2.07 | 2.11 | 1.94 | 1.96 |
| Operating cash flow | $131.7M | $144.5M | $127.4M | $93.8M |
| Cash | $221.9M | $258.9M | $187.2M | $161.5M |
| Buybacks | $97.1M | $5.7M | $24.2M | $155.9M |
| Dividends paid | $60.4M | $56.8M | $52.7M | $49.1M |
SEC XBRL, fiscal years, as known on 2026-10-28
EXPO Stock Sonar score 5/7 axes
Find similar shapesCompareEXPO ranks highest on profitability (89th percentile) and institutional and government (67th), and lowest on risk and compliance (43rd), among Services peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
EXPO filings, in plain words
Are Exponent insiders buying or selling EXPO?
In the 180 days to 2026-10-28, Exponent insiders were net sellers, a net $1.2M: $12.6K of purchases and $1.2M of sales reported on Form 4, by 1 buyer and 5 sellers.
Have members of Congress traded EXPO?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Lisa McClain dated 2025-09-11.
Are there planned insider sales of EXPO?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $114.5K of stock; the latest, by CATHERINE CORRIGAN, was filed 2026-08-17.
Read the full summary
In the 180 days to 2026-10-28, Exponent insiders were net sellers of EXPO, a net $1.2M across purchases and sales reported on Form 4 by 1 buyer and 5 sellers. Sales outweighed purchases more than tenfold by value. None of the 10 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in EXPO, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-09-11. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $114.5K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
